...
首页> 外文期刊>BMC Public Health >Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study
【24h】

Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study

机译:肯尼亚沿海农村HIV诊所成年人抗逆转录病毒治疗的流失率和预测因素:一项回顾性队列研究

获取原文

摘要

Background Scale up of antiretroviral therapy (ART) has led to substantial declines in HIV related morbidity and mortality. However, attrition from ART care remains a major public health concern and has been identified as one of the key reportable indicators in assessing the success of ART programs. This study describes the incidence and predictors of attrition among adults initiating ART in a rural HIV clinic in Coastal Kenya. Methods A retrospective cohort study design was used. Adults (≥15?years) initiated ART between January 2008 and December 2010 were followed up for two years. Attrition was defined as individuals who were either reported dead or lost to follow up (LFU, ≥ 180?days late since the last clinic visit). Kaplan Meier survival probabilities and Weibull baseline hazard regression analyses were used to model the incidence and predictors of time to attrition. Results Of the 928 eligible participants, 308 (33.2% [95% CI, 30.2 – 36.3]) underwent attrition at an incident rate of 23.1 (95% CI, 20.6 – 25.8)/100 pyo. Attrition at 6 and 12?months was 18.4% (95% CI, 16.0 – 21.1) and 23.2% (95% CI, 19.9 – 25.3) respectively. Gender (male vs. female, adjusted hazard ratio [95% CI], p-value: 1.5 [1.1 – 2.0], p?=?0.014), age (15 – 24 vs. ≥ 45?years, 2.2 [1.3 – 3.7], p?=?0.034) and baseline CD4 T-cell count (100 – 350 cells/uL vs. Conclusions A third of individuals initiating ART were either reported dead or LFU during two years of care, with more than a half of these occurring within six months of treatment initiation. Practical and sustainable biomedical interventions and psychosocial support systems are warranted to improve ART retention in this setting.
机译:背景技术扩大抗逆转录病毒疗法(ART)已导致与HIV相关的发病率和死亡率大幅下降。但是,抗逆转录病毒疗法的流失仍然是主要的公共卫生问题,已被确定为评估抗逆转录病毒疗法计划成功与否的关键可报告指标之一。这项研究描述了肯尼亚沿海农村艾滋病诊所中开始抗病毒治疗的成年人中流失的发生率和预测因素。方法采用回顾性队列研究设计。在2008年1月至2010年12月之间进行抗逆转录病毒治疗的成人(≥15岁),随访了两年。流失的定义是被报告死亡或失访的个体(LFU,自上次诊所就诊以来晚于≥180天)。 Kaplan Meier生存概率和Weibull基线风险回归分析用于建模损耗发生时间和预测时间的指标。结果在928名合格参与者中,有308名(33.2%[95%CI,30.2 – 36.3])流失,发生率为23.1(95%CI,20.6 – 25.8)/ 100 pyo。 6和12个月时的损耗分别为18.4%(95%CI,16.0 – 21.1)和23.2%(95%CI,19.9 – 25.3)。性别(男性对女性,调整后的危险比[95%CI],p值:1.5 [1.1 – 2.0],p?=?0.014),年龄(15 – 24岁,≥45岁,2.2 [1.3 – [3.7],p?=?0.034)和基线CD4 T细胞计数(100 – 350个细胞/微升vs.结论)三分之一接受抗逆转录病毒治疗的患者在两年的护理期间被报告死亡或LFU,其中一半以上为这些需要在治疗开始后的六个月内发生,因此有必要采取切实可行的可持续生物医学干预措施和社会心理支持系统,以改善这种情况下的抗逆转录病毒治疗的挽留率。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号